Diabetes Mellitus, Transient Neonatal, 1
Description
Neonatal diabetes mellitus (NDM), defined as insulin-requiring hyperglycemia within the first month of life, is a rare entity, with an estimated incidence of 1 in 400,000 neonates (Shield, 2000). In about half of the neonates, diabetes is transient and resolves at a median age of 3 months, whereas the rest have a permanent form of diabetes (OMIM ). In a significant number of patients with transient neonatal diabetes mellitus, type II diabetes appears later in life (Arthur et al., 1997).The major cause of transient neonatal diabetes (TND) is aberrant expression of imprinted genes at chromosome 6q24, associated in 20% of cases with DNA hypomethylation at the TND differentially methylated region (DMR), which lies within the imprinted promoter of the PLAGL1 gene ({603044}; Mackay et al., 2005). Over 50% of individuals with TND and hypomethylation at 6q24 also show mosaic DNA hypomethylation at other imprinted loci throughout the genome and a range of additional clinical features.
Genes related to Diabetes Mellitus, Transient Neonatal, 1
- ZFP57
- PLAGL1
Clinical Features
Top most frequent phenotypes and symptoms related to Diabetes Mellitus, Transient Neonatal, 1
- Growth delay
- Hypertelorism
- Failure to thrive
- Intrauterine growth retardation
- Talipes equinovarus
- Diabetes mellitus
- Small for gestational age
- Macroglossia
- Overgrowth
- Dehydration
And another 8 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Diabetes Mellitus, Transient Neonatal, 1 Is also known as tndm1, dmtn, tndm.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Diabetes Mellitus, Transient Neonatal, 1 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
![]() By Genetic Services Laboratory University of Chicago (United States).
BLK, SLC2A2, STAT3, KLF11, WFS1, ZBTB20, NEUROG3, LRBA, CDKN1C, CEL, IER3IP1, ZFP57, RFX6, CP, PTF1A, APPL1, CISD2, TRMT10A, GLIS3, DUT , (...)
View the complete list with 21 more genes
Specificity
3 %
Genes
50 % |
![]() By Genetic Services Laboratory University of Chicago (United States).
BLK, SLC2A2, STAT3, KLF11, WFS1, ZBTB20, NEUROG3, LRBA, CDKN1C, CEL, IER3IP1, ZFP57, RFX6, CP, PTF1A, APPL1, CISD2, TRMT10A, GLIS3, DUT , (...)
View the complete list with 21 more genes
Specificity
3 %
Genes
50 % |
![]() By Genetic Services Laboratory University of Chicago (United States).
ZFP57, EIF2AK3, GATA4, GATA6, GCK, MNX1, HYMAI, ABCC8, INS, FOXP3, PDX1, KCNJ11, NKX2-2, PLAGL1
Specificity
15 %
Genes
100 % |
![]() By Genetic Services Laboratory University of Chicago (United States).
ZFP57, EIF2AK3, GCK, ABCC8, INS, FOXP3, PDX1, KCNJ11
Specificity
13 %
Genes
50 % |
![]() By Genetic Services Laboratory University of Chicago (United States).
ZFP57, EIF2AK3, GATA4, GATA6, GCK, MNX1, ABCC8, INS, FOXP3, PDX1, KCNJ11, NKX2-2
Specificity
9 %
Genes
50 % |
![]() By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
ZFP57
Specificity
100 %
Genes
50 % |
![]() By CGC Genetics (Portugal).
ZFP57
Specificity
100 %
Genes
50 % |
![]() By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders (Germany).
ZFP57
Specificity
100 %
Genes
50 % |
You can get up to 18 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF, X-LINKED; CBAVDX PHELAN-MCDERMID SYNDROME; PHMDS VAN DEN ENDE-GUPTA SYNDROME; VDEGS HARTSFIELD SYNDROME; HRTFDS CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo; CDG2O ALPHA-2-MACROGLOBULIN DEFICIENCY; A2MD MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29